105 related articles for article (PubMed ID: 21803871)
1. Role for PKCβ in enhanced endothelin-1-induced pulmonary vasoconstrictor reactivity following intermittent hypoxia.
Snow JB; Gonzalez Bosc LV; Kanagy NL; Walker BR; Resta TC
Am J Physiol Lung Cell Mol Physiol; 2011 Nov; 301(5):L745-54. PubMed ID: 21803871
[TBL] [Abstract][Full Text] [Related]
2. Augmented Pulmonary Vasoconstrictor Reactivity after Chronic Hypoxia Requires Src Kinase and Epidermal Growth Factor Receptor Signaling.
Norton CE; Sheak JR; Yan S; Weise-Cross L; Jernigan NL; Walker BR; Resta TC
Am J Respir Cell Mol Biol; 2020 Jan; 62(1):61-73. PubMed ID: 31264901
[TBL] [Abstract][Full Text] [Related]
3. Chronic hypoxia upregulates pulmonary arterial ASIC1: a novel mechanism of enhanced store-operated Ca2+ entry and receptor-dependent vasoconstriction.
Jernigan NL; Herbert LM; Walker BR; Resta TC
Am J Physiol Cell Physiol; 2012 Mar; 302(6):C931-40. PubMed ID: 22205392
[TBL] [Abstract][Full Text] [Related]
4. Role of ASIC1 in the development of chronic hypoxia-induced pulmonary hypertension.
Nitta CH; Osmond DA; Herbert LM; Beasley BF; Resta TC; Walker BR; Jernigan NL
Am J Physiol Heart Circ Physiol; 2014 Jan; 306(1):H41-52. PubMed ID: 24186095
[TBL] [Abstract][Full Text] [Related]
5. Rho kinase and Na
Huetsch JC; Walker J; Undem C; Lade J; Yun X; Baksh S; Jiang H; Lai N; Shimoda LA
Physiol Rep; 2018 May; 6(9):e13698. PubMed ID: 29756391
[TBL] [Abstract][Full Text] [Related]
6. Gap junctions support the sustained phase of hypoxic pulmonary vasoconstriction by facilitating calcium sensitization.
Kizub IV; Strielkov IV; Shaifta Y; Becker S; Prieto-Lloret J; Snetkov VA; Soloviev AI; Aaronson PI; Ward JP
Cardiovasc Res; 2013 Aug; 99(3):404-11. PubMed ID: 23708740
[TBL] [Abstract][Full Text] [Related]
7. Endothelin-1-Rho kinase interactions impair lung structure and cause pulmonary hypertension after bleomycin exposure in neonatal rat pups.
Gien J; Tseng N; Seedorf G; Kuhn K; Abman SH
Am J Physiol Lung Cell Mol Physiol; 2016 Dec; 311(6):L1090-L1100. PubMed ID: 27760762
[TBL] [Abstract][Full Text] [Related]
8. Low concentrations of sphingosylphosphorylcholine enhance pulmonary artery vasoreactivity: the role of protein kinase C delta and Ca2+ entry.
Snetkov VA; Thomas GD; Teague B; Leach RM; Shaifta Y; Knock GA; Aaronson PI; Ward JP
Hypertension; 2008 Feb; 51(2):239-45. PubMed ID: 18158336
[TBL] [Abstract][Full Text] [Related]
9. Effects of acute Rho kinase inhibition on chronic hypoxia-induced changes in proximal and distal pulmonary arterial structure and function.
Vanderpool RR; Kim AR; Molthen R; Chesler NC
J Appl Physiol (1985); 2011 Jan; 110(1):188-98. PubMed ID: 21088209
[TBL] [Abstract][Full Text] [Related]
10. Contribution of Mitochondrial Reactive Oxygen Species to Chronic Hypoxia-Induced Pulmonary Hypertension.
Yan S; Sheak JR; Walker BR; Jernigan NL; Resta TC
Antioxidants (Basel); 2023 Nov; 12(12):. PubMed ID: 38136180
[TBL] [Abstract][Full Text] [Related]
11. Endothelin-1 induces contraction of female rat internal pudendal and clitoral arteries through ET(A) receptor and rho-kinase activation.
Allahdadi KJ; Hannan JL; Tostes RC; Webb RC
J Sex Med; 2010 Jun; 7(6):2096-2103. PubMed ID: 20412427
[TBL] [Abstract][Full Text] [Related]
12. Renal biomarkers of acute kidney injury in response to increasing intermittent hypoxia episodes in the neonatal rat.
Zangaladze A; Cai CL; Marcelino M; Aranda JV; Beharry KD
BMC Nephrol; 2021 Sep; 22(1):299. PubMed ID: 34481475
[TBL] [Abstract][Full Text] [Related]
13. Endothelin-1 as a novel target for the prevention of metabolic dysfunction with intermittent hypoxia in male participants.
Limberg JK; Baker SE; Petersen-Jones HG; Guo W; Huang A; Jensen MD; Singh P
Am J Physiol Regul Integr Comp Physiol; 2022 Sep; 323(3):R351-R362. PubMed ID: 35816718
[TBL] [Abstract][Full Text] [Related]
14. [Pulmonary hypertension: calcium channel-mediated signaling, present and future pharmacological targets].
Acuña B; Bello-Zepeda J; Montenegro G; Reyes RV
Rev Med Chil; 2023 Jun; 151(6):753-763. PubMed ID: 38801384
[TBL] [Abstract][Full Text] [Related]
15. Vasoconstrictor Mechanisms in Chronic Hypoxia-Induced Pulmonary Hypertension: Role of Oxidant Signaling.
Yan S; Resta TC; Jernigan NL
Antioxidants (Basel); 2020 Oct; 9(10):. PubMed ID: 33076504
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia-inducible factors activator, roxadustat, increases pulmonary vascular resistance in rats.
Novák T; Žaloudíková M; Smolková P; Kaftanová B; Edlmanová J; Krása K; Hampl V
Physiol Res; 2023 Dec; 72(S5):S587-S592. PubMed ID: 38165762
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary vascular and ventricular dysfunction in the susceptible patient (2015 Grover Conference series).
Maron BA; Machado RF; Shimoda L
Pulm Circ; 2016 Dec; 6(4):426-438. PubMed ID: 28090285
[TBL] [Abstract][Full Text] [Related]
18. Maladaptive Pulmonary Vascular Responses to Chronic Sustained and Chronic Intermittent Hypoxia in Rat.
Prieto-Lloret J; Olea E; Gordillo-Cano A; Docio I; Obeso A; Gomez-Niño A; Aaronson PI; Rocher A
Antioxidants (Basel); 2021 Dec; 11(1):. PubMed ID: 35052557
[TBL] [Abstract][Full Text] [Related]
19. Characterization of Contractile Machinery of Vascular Smooth Muscles in Hypertension.
Yang Q; Hori M
Life (Basel); 2021 Jul; 11(7):. PubMed ID: 34357074
[TBL] [Abstract][Full Text] [Related]
20. Intermittent Hypoxia Augments Pulmonary Vasoconstrictor Reactivity through PKCβ/Mitochondrial Oxidant Signaling.
Snow JB; Norton CE; Sands MA; Weise-Cross L; Yan S; Herbert LM; Sheak JR; Gonzalez Bosc LV; Walker BR; Kanagy NL; Jernigan NL; Resta TC
Am J Respir Cell Mol Biol; 2020 Jun; 62(6):732-746. PubMed ID: 32048876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
